BCCCP: Immobility and Early Mobilization

Question 1 of 10

1. Question

Which of the following statements about the epidemiology and impact of ICU-acquired weakness and immobility-related complications is most accurate?

ICU-acquired weakness affects approximately 25–50% of critically ill patients requiring mechanical ventilation for more than one week.
Early mobilization protocols have reduced the incidence of immobility-related complications to under 10% among ICU patients.
ICU-acquired weakness typically shows substantial improvement within one week after ICU discharge.
Immobility-related complications have minimal impact on long-term morbidity and mortality in ICU survivors.

Question 2 of 10

2. Question

Analyze how social determinants of health such as medication access and health literacy can serve as precipitating risk factors for immobility and delayed mobilization in critically ill patients in the ICU.

Limited medication access can result in untreated pain or symptoms, leading to decreased mobility.
Low health literacy can impair understanding of mobilization protocols, delaying patient participation in physical therapy.
Socioeconomic factors have no impact on a patient’s ability to mobilize early in the ICU.
Access to social support networks does not influence recovery speed or mobility outcomes in critical care.

Question 3 of 10

3. Question

In critically ill ICU patients requiring pharmacologic venous thromboembolism (VTE) prophylaxis, which of the following agents has the most predictable pharmacokinetics with minimal routine laboratory monitoring and a lower risk of heparin-induced thrombocytopenia (HIT), albeit at a higher acquisition cost?

Unfractionated heparin (UFH) subcutaneous
Low molecular weight heparin (LMWH) subcutaneous
Direct oral anticoagulants (DOACs)
Fondaparinux subcutaneous

Question 4 of 10

4. Question

Recommend second-line or adjunctive therapies (e.g., minimization of neuromuscular blocking agents, corticosteroid avoidance) based on patient response and guidelines.

Continue neuromuscular blocking agents indefinitely without evaluation.
Avoid corticosteroids in all patients irrespective of clinical scenario.
Adjust therapies such as neuromuscular blocking agents and corticosteroids based on patient response and current guidelines.
Disregard patient response and follow a fixed treatment protocol for all.

Question 5 of 10

5. Question

Management of iatrogenic complications arising from ICU therapies is crucial. Which of the following is the most appropriate management for heparin-induced thrombocytopenia (HIT)?

Continue heparin at a reduced dose and monitor platelet counts closely.
Stop heparin and initiate an alternative anticoagulant such as argatroban or bivalirudin.
Administer platelet transfusions immediately to increase platelet count.
Ignore thrombocytopenia unless bleeding develops.

Question 6 of 10

6. Question

Which of the following best represents a comprehensive medication reconciliation and discharge counseling plan for an ICU patient to ensure a safe transition to the next level of care?

Conduct a thorough reconciliation of all current and prior medications (including dosages, routes, and frequencies), provide written documentation of the reconciled list, deliver verbal handoff communication to the receiving care team, and engage the patient and/or family in discharge counseling on the medication regimen.
Perform a thorough reconciliation of all current and prior medications (including dosages and frequencies) and provide only written documentation of the reconciled list, without verbal handoff or patient/family counseling.
Reconcile only newly prescribed medications at ICU discharge, supplement the process with written documentation and verbal handoff, but exclude chronic preadmission medications.
Rely on pharmacist-led review of current and prior medications with verbal handoff and patient/family counseling, but omit written documentation of the reconciled regimen.

Question 7 of 10

7. Question

Which tool is most appropriate for monitoring the depth of sedation in adult ICU patients receiving continuous sedative infusions?

Monitoring pain scores with patient self-report scales such as the Numeric Rating Scale or the Behavioral Pain Scale.
Assessing sedation levels using the Richmond Agitation-Sedation Scale (RASS) to guide titration of sedative infusions.
Evaluating respiratory depression through continuous monitoring of respiratory rate and oxygen saturation.
Monitoring laboratory parameters and clinical signs for bleeding when anticoagulants or antiplatelets are used concurrently.

Question 8 of 10

8. Question

Identify the appropriate route of administration and necessary delivery devices for analgesia, sedation, and anticoagulation in critically ill patients in the ICU.

Intravenous infusion using continuous pump for analgesia and sedation; subcutaneous injection for anticoagulation.
Oral administration for all three therapies to reduce invasiveness.
Intramuscular injection for rapid sedation and anticoagulation; intravenous bolus for analgesia.
Transdermal patches for analgesia and sedation; oral anticoagulants.

Question 9 of 10

9. Question

What key supportive care measures should be implemented to facilitate safe early mobilization in critically ill ICU patients?

Increase ventilator tidal volume to improve oxygenation during mobilization.
Maintain hemodynamic stability by titrating vasopressors before initiating mobilization.
Proceed with early mobilization without adjusting sedation or ventilation parameters.
Avoid any mechanical ventilation adjustments to prevent patient discomfort during mobilization.

Question 10 of 10

10. Question

A 56-year-old patient in the ICU who has been mechanically ventilated for two weeks develops generalized symmetric muscle weakness. Sedation precludes reliable bedside strength testing. Which diagnostic test is most appropriate to confirm ICU-acquired weakness and exclude other neuromuscular causes?

Measurement of serum creatine kinase (CK) levels
Electromyography (EMG) combined with nerve conduction studies (NCS)
Percutaneous quadriceps muscle biopsy
Magnetic resonance imaging (MRI) of the brain

Quiz Summary

Information

Results